tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Skye Bioscience (SKYE)
NASDAQ:SKYE
US Market
SKYE
Skye Bioscience
RESEARCH TOOLSreports

Skye Bioscience (SKYE) Stock News & Sentiment

Compare
948 Followers
Skye Bioscience Faces Nasdaq Listing Compliance Deficiency Notice
Premium
Company Announcements
Skye Bioscience Faces Nasdaq Listing Compliance Deficiency Notice
3d ago
8K
SKYE
SKYE Bioscience: Advancing Nimacimab Dose Expansion and Clear Phase 2b Path as Adjunct to Semaglutide Supports Buy Rating
Premium
Ratings
SKYE Bioscience: Advancing Nimacimab Dose Expansion and Clear Phase 2b Path as Adjunct to Semaglutide Supports Buy Rating
11d ago
SKYE
SKYE Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SKYE Upcoming Earnings Report: What to Expect?
15d ago
SKYE
Skye Bioscience: Nimacimab’s Emerging Clinical Profile and Undervalued Asymmetric Risk/Reward Support Buy Rating
Premium
Ratings
Skye Bioscience: Nimacimab’s Emerging Clinical Profile and Undervalued Asymmetric Risk/Reward Support Buy Rating
2M ago
SKYE
Skye Bioscience Reports Promising Phase 2a Obesity Data
Premium
Company Announcements
Skye Bioscience Reports Promising Phase 2a Obesity Data
2M ago
8K
SKYE
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—1/14/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—1/14/26
2M ago
CLB
VTI
What Investors Can Learn from the Skye Bioscience Securities Fraud Allegations: A Risk Assessment Guide
Premium
Class Action
What Investors Can Learn from the Skye Bioscience Securities Fraud Allegations: A Risk Assessment Guide
2M ago
SKYE
More SKYE News >

SKYE News on the Web

Skye Bioscience Faces Nasdaq Listing Compliance Deficiency Notice
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and Skye Bioscience (SKYE)
TipRanks News
Bullish
Piper Sandler Sticks to Its Buy Rating for Skye Bioscience (SKYE)
TipRanks News
Bullish
Skye Bioscience Inc (SKYE) Q4 2025 Earnings Call Highlights: Pioneering Advances in Obesity ...
GuruFocus News
Bullish
Skye Bioscience (SKYE) Receives a Hold from Cantor Fitzgerald
TipRanks News
Neutral
SKYE Bioscience: Advancing Nimacimab Dose Expansion and Clear Phase 2b Path as Adjunct to Semaglutide Supports Buy Rating
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), BioNTech SE (BNTX) and Skye Bioscience (SKYE)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Skye Bioscience (SKYE) and Sandoz Group Ltd (OtherSDZXF)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
SKYE
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.75 articles
News Sentiment
This Week0%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SKYE’s Media Buzz Sentiment?
1 articles about SKYE were published this week. In an average week, 2.75 articles are published.
    What is SKYE’s weekly average amount of articles?
    In an average week, 2.75 articles about SKYE are published.
      What is SKYE’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      KHTRFKnight Therapeutics
      ABOSAcumen Pharmaceuticals
      KMTSKestra Medical Technologies Ltd.
      MISTMilestone Pharmaceuticals
      OVIDOvid Therapeutics
      Showing the stocks with the most bullish news sentiment over the past week